| [1］American Diabetes Association.Standards of Medical Care in Diabetes-2014［J］.Diabetes Care，2014，37(suppl 1)：14-80. [2］International Diabetes Federation.Global Guideline for Type 2 Diabetes,2012. [3］International Diabetes Federation.Managing Older People with Type 2 Diabetes Global Guideline,2013，Geneva [4］American Association of Clinical Endocrinologists.Medical Guideline for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan［J］.Endocrine Practice，2011，17(suppl 2)：1-53. [5］Wang W，Bu R，Su Q，et al.Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy［J］.Expert Opin Pharmacother，2011，12(18)：2791-2799. [6］Lund SS，Tarnow L，Frandsen M，et al.Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes：12 month，randomised，double blind trial［J］.BMJ，2009，339：b4324. [7］中国医师协会内分泌代谢科医师分会.2型糖尿病合并慢性肾脏病患者口服降糖药用药原则中国专家共识［J］.中国糖尿病杂志，2013，10(21)：865-870. [8］U.K.Prospective Diabetes Study Group.Overview of 6 Years’ Therapy of Type Ⅱ Diabetes：A Progressive Disease ［J］.Diabetes，1995，44(11)：1249-1258. [9］Rahier J，Guiot Y，Henquin JC，et al.Pancreatic b-cell mass in European subjects with type 2 diabetes［J］.Diabetes，Obesity and Metabolism，2008，10 (Suppl 4)，32-42. |
